IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q3 2019 Holdings

Filed 2019-11-14 | 8 holdings | $32.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$32.2M3,540,85099.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$223.9K16,166,9070.7%
Constellation Pharmceticls I(CNST)COM210373106$38.8K6,009,7020.1%
Gritstone Oncology Inc(2JQ)COM39868T105$26.8K3,102,9340.1%